(3S,7aR,11aR)-3-isopropyl-9-(4-methoxybenzyl)octahydrooxazolo[2,3-j][1,6]naphthyridin-5(6H)-one

ID: ALA5206556

PubChem CID: 168296252

Max Phase: Preclinical

Molecular Formula: C21H30N2O3

Molecular Weight: 358.48

Names and Identifiers

Canonical SMILES:  COc1ccc(CN2CC[C@]34OC[C@H](C(C)C)N3C(=O)CC[C@@H]4C2)cc1

Standard InChI:  InChI=1S/C21H30N2O3/c1-15(2)19-14-26-21-10-11-22(12-16-4-7-18(25-3)8-5-16)13-17(21)6-9-20(24)23(19)21/h4-5,7-8,15,17,19H,6,9-14H2,1-3H3/t17-,19-,21-/m1/s1

Standard InChI Key:  YLBHJBBTUJVMCK-YFVAEKQCSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -1.6015    0.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    0.8321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1726    0.4196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1726   -0.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870   -0.8177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6015   -0.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870    1.6571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1725    2.0695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5418    1.6570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5418    0.8321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6715    1.9120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6716    0.5772    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1564    1.2447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1725    2.8942    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8849    2.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8870   -1.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1728   -2.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5415   -1.6426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2531   -2.0544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2531   -2.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5432   -3.2910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1728   -2.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5415    0.0073    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.9673   -3.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6815    2.9220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3018    3.2917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6815   -2.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  2  7  1  6
  8  7  1  0
  9  8  1  0
 10  9  1  0
  3 10  1  0
  7 11  1  0
  2 12  1  0
 12 13  1  0
 13 11  1  0
  8 14  2  0
 11 15  1  6
  5 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 17 22  1  0
  3 23  1  1
 20 24  1  0
 15 25  1  0
 15 26  1  0
 24 27  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5206556

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 358.48

Molecular Weight (Monoisotopic): 358.2256

AlogP: 2.89

#Rotatable Bonds: 4

Polar Surface Area: 42.01

Molecular Species: NEUTRAL

HBA: 4

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.48

CX LogP: 3.18

CX LogD: 2.07

Aromatic Rings: 1

Heavy Atoms: 26

QED Weighted: 0.83

Np Likeness Score: -0.09

References

1. Dam S, Tangara S, Hamela C, Hattabi T, Faïon L, Carre P, Antoine R, Herledan A, Leroux F, Piveteau C, Eveque M, Flipo M, Deprez B, Kremer L, Willand N, Villemagne B, Hartkoorn RC..  (2022)  Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases.,  65  (24.0): [PMID:36473699] [10.1021/acs.jmedchem.2c01493]

Source

Source(1):

• Scientific Literature